Anti-pd-1 antibodies and methods of making and using thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SYSTIMMUNE INC
- Publication Date
- 2020-02-14
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
[0001] Cross References to Related Applications
[0002] This application claims U.S. Provisional Patent Application No. 62545603, filed August 15, 2017, U.S. Provisional Patent Application No. 62524553, filed June 25, 2017, U.S. Provisional Patent Application No. 62524554, filed June 25, 2017 , U.S. Provisional Patent Application No. 62524557, filed June 25, 2017, and U.S. Provisional Patent Application No. 62524558, filed June 25, 2017, which are expressly incorporated herein by reference in their entirety. technical field
[0003] This application generally relates to the field of antibody technology, and more specifically relates to the preparation and use of anti-PD-1 antibodies. Background technique
[0004] Cancer is a major health problem worldwide. In the United States alone, an estimated 1,685,210 new cancer cases were diagnosed and 595,690 deaths occurred in 2016 (http: / / www.cancer.gov). Therefore, any agent that reduces cancer severity or mortality is desirable...